Virtu Financial LLC Timber Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.24 - $0.39 $2,616 - $4,251	10,901 New	10,901 $3,000
Q1 2022 May 17, 2022	SELL	$0.28 - $0.41 $48,678 - $71,279	-173,852 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.38 - $0.89 $49,438 - $115,790	130,102 Added 297.38%	173,852 $66,000
Q3 2021 Nov 12, 2021	SELL	$0.89 - $1.18 $19,694 - $26,112	-22,129 Reduced 33.59%	43,750 $40,000
Q2 2021 Sep 17, 2021	BUY	$1.06 - $2.25 $69,831 - $148,227	65,879 New	65,879 $80,000
Q4 2020 Feb 24, 2021	SELL	$0.72 - $1.52 $7,841 - $16,554	-10,891 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$0.92 - $2.4 $10,019 - $26,138	10,891 New	10,891 $11,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.